|
Summary
April 2007, Vol. 3, No. 2, Pages 235-249
, DOI 10.1517/17425255.3.2.235
Whole-body physiologically based pharmacokinetic modelsIvan NestorovZymogenetics Inc., 1201 Eastlake Avenue East, Seattle, Washington 98102, USAE-mail: intv@zgi.com This review summarizes the most recent developments in and applications of physiologically based pharmacokinetic (PBPK) modeling methodology originating from both the pharmaceutical and environmental toxicology areas. It focusses on works published in the last 5 years, although older seminal papers have also been referenced. After a brief introduction to the field and several essential definitions, the main body of the text is structured to follow the major steps of a typical PBPK modeling exercise. Various applications of the methodology are briefly described. The major future trends and perspectives are outlined. The main conclusion from the review of the available literature is that PBPK modeling, despite its obvious potential and recent incremental developments, has not taken the place it deserves, especially in pharmaceutical and drug development sciences. Forward Links to Citing ArticlesDonald E. MAGER, Sukyung WOO, William J. JUSKO. (2009) Scaling Pharmacodynamics from In Vitro and Preclinical Animal Studies to Humans. Drug Metabolism and Pharmacokinetics 24:1, 16-24 Online publication date: 1-Feb-2009. CrossRef Masoud JAMEI, Gemma L DICKINSON, Amin ROSTAMI-HODJEGAN. (2009) A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates. Drug Metabolism and Pharmacokinetics 24:1, 53-75 Online publication date: 1-Feb-2009. CrossRef Stefan Willmann. (2009) Das
In-silico-Child
. Können Computer-Simulationen klinisch-pharmakokinetische Studien ersetzen?. Pharmazie in unserer Zeit 38:1, 62-67 Online publication date: 1-Feb-2009. CrossRef F. Bouzom, B. Walther. (2009) Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling. Fundamental & Clinical Pharmacology 22:6, 579-587 Online publication date: 1-Jan-2009. CrossRef Andrea N Edginton, Frank-Peter Theil, Walter Schmitt, Stefan Willmann. (2008) Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opinion on Drug Metabolism & Toxicology 4:9, 1143-1152 Online publication date: 1-Sep-2008. Summary | Full Text | PDF (313 KB) | PDF Plus (271 KB) Kok-Yong Seng, Ivan Nestorov, Paolo Vicini. (2008) Physiologically Based Pharmacokinetic Modeling of Drug Disposition in Rat and Human: A Fuzzy Arithmetic Approach. Pharmaceutical Research 25:8, 1771-1781 Online publication date: 1-Sep-2008. CrossRef Sheila Annie Peters. (2008) Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Lineshape Analysis. Clinical Pharmacokinetics 47:4, 261-275 Online publication date: 1-Feb-2008. CrossRef Stefan S De Buck, Claire E Mackie. (2007) Physiologically based approaches towards the prediction of pharmacokinetics: in vitro–in vivo extrapolation. Expert Opinion on Drug Metabolism & Toxicology 3:6, 865-878 Online publication date: 1-Dec-2007. Summary | Full Text | PDF (234 KB) | PDF Plus (423 KB) T. Lavé, N. Parrott, H. P. Grimm, A. Fleury, M. Reddy. (2007) Challenges and opportunities with modelling and simulation in drug discovery and drug development. Xenobiotica 37:10-11, 1295-1310 Online publication date: 1-Nov-2007. Summary | Full Text | PDF (232 KB) | PDF Plus (294 KB) K. Sandy Pang, Michael Weiss, Panos Macheras. (2007) Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts. The AAPS Journal 9:2, E268-E283 Online publication date: 1-Jul-2007. CrossRef Users who read this article also read:
|
|





TOC Alert